Sight Sciences ex-officer plans sale of 13K shares

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) is the issuer for a planned sale of common stock reported under Rule 144 for the account of former officer Jeremy B. Hayden. A brokerage account at Fidelity Brokerage Services LLC filed notice to sell up to 13,253 shares of SGHT common stock, with an indicated value of $109,974.72. The securities relate to restricted stock vesting on 08/31/2026, received from the issuer as compensation. The filer notes that the sale includes an amount necessary to cover a tax obligation arising from settlement of a vested equity award.

In the prior three months, Jeremy Hayden reported several open-market sales of SGHT common stock, including 12,733 shares on 07/06/2026 for $70,132.10 and 48,000 shares on 08/14/2026 for $395,880.00, along with additional transactions on 08/11/2026, 08/12/2026, 08/13/2026, and 08/17/2026.

Key Figures

Planned shares to be sold: 13,253 shares Planned sale value: $109,974.72 Restricted stock vesting date: 08/31/2026 +4 more

7 metrics

Planned shares to be sold 13,253 shares Shares of Sight Sciences, Inc. common stock covered by the Form 144 notice

Planned sale value $109,974.72 Indicated value for the 13,253 SGHT shares to be sold

Restricted stock vesting date 08/31/2026 Date of restricted stock vesting giving rise to the securities

Sale on 07/06/2026 12,733 shares for $70,132.10 Common stock sale by Jeremy Hayden during past three months

Sale on 08/11/2026 20,918 shares for $165,878.62 Common stock sale by Jeremy Hayden during past three months

Sale on 08/14/2026 48,000 shares for $395,880.00 Largest listed sale of SGHT common stock in the period

Sale on 08/17/2026 12,014 shares for $97,841.48 Common stock sale by Jeremy Hayden during past three months

Key Terms

Rule 144, restricted stock vesting, equity award distribution, attorney-in-fact, +1 more

5 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 08/31/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

equity award distribution financial

"resulting from the settlement of a vested equity award distribution."

attorney-in-fact regulatory

"as attorney-in-fact for Jeremy Hayden"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

tax obligation financial

"Sale includes an amount necessary to cover a tax obligation"

FAQ

What does the Form 144 filing for SGHT disclose about Jeremy Hayden's planned sale?

The notice covers a planned sale of up to 13,253 shares of Sight Sciences, Inc. (SGHT) common stock, with an indicated value of $109,974.72. The securities arise from restricted stock vesting on 08/31/2026 and were received from the issuer as compensation.

Who is selling Sight Sciences (SGHT) shares in this Form 144 and in what capacity?

The sale is for the account of Jeremy B. Hayden, identified as a former officer of Sight Sciences, Inc. Fidelity Brokerage Services LLC submitted the notice, acting under a power of attorney as attorney-in-fact for Jeremy Hayden.

How many SGHT shares did Jeremy Hayden sell in the past three months according to the Form 144?

The notice lists multiple sales: 12,733 shares for $70,132.10 on 07/06/2026; 20,918 shares for $165,878.62 on 08/11/2026; 16,302 shares for $133,307.09 on 08/12/2026; 2,500 shares for $20,762.50 on 08/13/2026; 48,000 shares for $395,880.00 on 08/14/2026; and 12,014 shares for $97,841.48 on 08/17/2026.

What is the reason for part of the SGHT share sale noted in the Form 144?

The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution, indicating that some proceeds are intended to satisfy tax liabilities from equity compensation.

On which market are the SGHT shares in this Form 144 traded?

The common stock referenced in the notice is identified as being traded on NASDAQ. The filing also lists the brokerage firm Fidelity Brokerage Services LLC as the intermediary holding the securities to be sold.

What types of SGHT securities are involved in this Form 144 filing?

The securities are common stock of Sight Sciences, Inc. They arose from restricted stock vesting on 08/31/2026 and were received from the issuer as compensation, according to the description in the notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 03:31 PM Accepted by SEC EDGAR 09/01/2026 - 03:30 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001650737
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Sight Sciences, Inc.
SEC File Number	001-40587
Address of Issuer	4040 CAMPBELL AVE, SUITE 100 MENLO PARK CALIFORNIA 94025
Phone	(415) 889-0550
Name of Person for Whose Account the Securities are To Be Sold	HAYDEN JEREMY B.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13253	109974.72	55087990	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/31/2026	Restricted Stock Vesting	Issuer			13253	08/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Jeremy Hayden 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	07/06/2026	12733	70132.10
Jeremy Hayden 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	08/11/2026	20918	165878.62
Jeremy Hayden 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	08/12/2026	16302	133307.09
Jeremy Hayden 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	08/13/2026	2500	20762.50
Jeremy Hayden 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	08/14/2026	48000	395880.00
Jeremy Hayden 4040 Campbell Ave Suite 100 Menlo Park CA 94025	Common	08/17/2026	12014	97841.48

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	09/01/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Margaret Campbell, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Jeremy Hayden
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)